Motavizumab(677010-34-3)
- Name: Motavizumab
- Synonyms:Numax
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:677010-34-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.677010-34-3 Motavizumab
Assay:99% Appearance:liquid Package:Inside plastic outside Storage:2-8掳C Transportation:We ship goods via DHL, Fedex, UPS, TNT, China post, NL Post and other couriers, weight from 1g to 1000kg or even bulker Application:Scientific research
Min. Order:1Gram
Supplier:Hebei Nengqian Chemical Import and Export Co., LTD [
China (Mainland)] CAS No.677010-34-3 Motavizumab
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.677010-34-3 Motavizumab
Assay:98%Min Appearance:detailed in specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by ocean shipping Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.677010-34-3 Motavizumab
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Motavizumab
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.677010-34-3 Motavizumab
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 308846-06-2/2-Cyano-5-bromomethylpyridine
- 86042-28-6/1,5-Di-O-(4-methylbenzoyl)-2,3-O-isopropylidene-beta-D-ribofuranose
- 34680-81-4/2-BROMO-N-METHYLACETAMIDE
- 65090-78-0/2-Bromo-3-methoxypropionic acid
- 321890-38-4/N-Methyl-1-methylazetidin-3-amine
- 56673-34-8/3-Bromo-6-mercaptopyridine
- 111454-71-8/3-Bromoisoxazole
- 22324-83-0/(+/-)-Cryptostyline III
- 882670-93-1/6-Bromo-2-iodoquinazoline
- 38035-10-8/4-(Dimethylamino)tetrahydro-2H-pyran
- 376587-52-9/5-Bromo-2-iodo-3-methylpyridine
- 80296-78-2/Cresol-formaldehyde copolymer 1,2-naphthoquinonediazido-4-sulfonate
- 76169-06-7/Cresol-formaldehyde copolymer 1,2-naphthoquinonediazide-5-sulfonate
- 319906-45-1/7-Bromo-2-iodo-9,9-dimethyl-9H-fluorene
- 26934-35-0/4-[3-(Dimethylamino)propoxy]benzaldehyde
- 143322-56-9/(R)-5-BROMO-3-[(1-METHYL-2-PYRROLIDINYL)METHYL]-1H-INDOLE
- 51690-03-0/1-Dimethylamino-2-methylpentan-3-one
- 40594-34-1/4-(Dimethylamino)cyclohexanone
- 172529-93-0/[2-(2-Amino-6-chloro-9H-purin-9-yl)ethyl]propanedioic acid dimethyl ester
- 677010-34-3/Motavizumab
- 957062-65-6/2-(Morpholinosulfonyl)phenylboronic acid
- 870521-33-8/2-Morpholinopyrimidin-5-ylboronic acid
- 125422-83-5/3-Morpholinopropyl bromide
- 89583-07-3/2-(4-Morpholine)ethyl bromide
- 8005-84-3/Mordant Brown 49
- 220621-22-7/Pentanedioic acid, 1-[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester
- 72000-65-8/2,5-Pyrrolidinedicarboxylicacid(6CI,7CI,9CI)
- 93713-35-0/2,5-Pyrrolidinedicarboxylicacid,(2R-trans)-(9CI)
- 81702-31-0/2,5-Pyrrolidinedicarboxylicacid,(2S,5S)-(9CI)
- 10589-94-3/Pyroporphyrin dimethyl ester